Susan E. Moore

902 total citations
12 papers, 712 citations indexed

About

Susan E. Moore is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Susan E. Moore has authored 12 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Susan E. Moore's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (3 papers) and Hepatitis B Virus Studies (3 papers). Susan E. Moore is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (3 papers) and Hepatitis B Virus Studies (3 papers). Susan E. Moore collaborates with scholars based in United States and Japan. Susan E. Moore's co-authors include Albert F. LoBuglio, D L Barlow, Robert M. Conry, David T. Curiel, Karen O. Allen, Frosty Loechel, L A Sumerel, R M Conry, Denise R. Shaw and Theresa V. Strong and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Human Gene Therapy and Journal of Immunotherapy.

In The Last Decade

Susan E. Moore

12 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Moore United States 11 483 370 211 208 85 12 712
Matthias Schroff Germany 16 316 0.7× 306 0.8× 125 0.6× 190 0.9× 30 0.4× 39 685
S Hashimoto Japan 15 205 0.4× 274 0.7× 115 0.5× 203 1.0× 75 0.9× 30 533
Gideon Gross Israel 15 324 0.7× 260 0.7× 391 1.9× 159 0.8× 126 1.5× 34 735
Jean‐Philippe Carralot Germany 12 442 0.9× 600 1.6× 121 0.6× 181 0.9× 19 0.2× 18 831
Oliver Höhn Germany 15 348 0.7× 347 0.9× 106 0.5× 178 0.9× 17 0.2× 26 863
Luciene Lopes United Kingdom 11 356 0.7× 225 0.6× 121 0.6× 212 1.0× 26 0.3× 13 569
Avital Lev Israel 15 513 1.1× 219 0.6× 223 1.1× 41 0.2× 162 1.9× 18 727
Ken Snoke United States 7 747 1.5× 309 0.8× 137 0.6× 32 0.2× 192 2.3× 9 949
Mario Cooper United States 11 143 0.3× 540 1.5× 152 0.7× 560 2.7× 43 0.5× 15 872
Peter Vaillancourt United States 11 116 0.2× 234 0.6× 116 0.5× 104 0.5× 109 1.3× 22 491

Countries citing papers authored by Susan E. Moore

Since Specialization
Citations

This map shows the geographic impact of Susan E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Moore more than expected).

Fields of papers citing papers by Susan E. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Moore. The network helps show where Susan E. Moore may publish in the future.

Co-authorship network of co-authors of Susan E. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Moore. A scholar is included among the top collaborators of Susan E. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Moore. Susan E. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Triozzi, Pierre L., Theresa V. Strong, R. Pat Bucy, et al.. (2005). Intratumoral Administration of a Recombinant Canarypox Virus Expressing Interleukin 12 in Patients with Metastatic Melanoma. Human Gene Therapy. 16(1). 91–100. 33 indexed citations
2.
Conry, Robert M., David T. Curiel, Theresa V. Strong, et al.. (2002). Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.. PubMed. 8(9). 2782–7. 109 indexed citations
3.
White, Stephen, Albert F. LoBuglio, Ramin B. Arani, et al.. (2000). Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine. The Journal of Gene Medicine. 2(2). 135–140. 19 indexed citations
4.
Lee, Seungwon, Hui Li, Theresa V. Strong, Susan E. Moore, & Robert M. Conry. (2000). Development of a Polynucleotide Vaccine from Melanoma Antigen Recognized by T Cells-1 and Recombinant Protein from Melanoma Antigen Recognized by T Cells-1 for Melanoma Vaccine Clinical Trials. Journal of Immunotherapy. 23(3). 379–386. 7 indexed citations
5.
Conry, Robert M., Karen O. Allen, Seungwon Lee, et al.. (2000). Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.. PubMed. 6(1). 34–41. 59 indexed citations
6.
Conry, R M, M B Khazaeli, Mansoor N. Saleh, et al.. (1999). Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.. PubMed. 5(9). 2330–7. 71 indexed citations
7.
Conry, R M, Stephen White, Patricia N. Fultz, et al.. (1998). Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.. PubMed. 4(11). 2903–12. 28 indexed citations
8.
Weed, Michael R., Ian A. Paul, Linda P. Dwoskin, Susan E. Moore, & William L. Woolverton. (1997). The Relationship between Reinforcing Effects and in Vitro Effects of D1 Agonists in Monkeys. Journal of Pharmacology and Experimental Therapeutics. 283(1). 29–38. 46 indexed citations
9.
Conry, Robert M., Georg Widera, Albert F. LoBuglio, et al.. (1996). Selected strategies to augment polynucleotide immunization.. PubMed. 3(1). 67–74. 97 indexed citations
10.
Conry, Robert M., Albert F. LoBuglio, Frosty Loechel, et al.. (1995). A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.. PubMed. 2(1). 59–65. 95 indexed citations
11.
Conry, R M, Albert F. LoBuglio, Frosty Loechel, et al.. (1995). A carcinoembryonic antigen polynucleotide vaccine for human clinical use.. PubMed. 2(1). 33–8. 52 indexed citations
12.
Conry, R M, Albert F. LoBuglio, Judy Kantor, et al.. (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine.. PubMed. 54(5). 1164–8. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026